메뉴 건너뛰기




Volumn 58, Issue 10, 2010, Pages 643-644

Serious neutropenia following etanercept administration in a 62 years female patient of rheumatoid arthritis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

EID: 78049238746     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (9)
  • 1
    • 34547800234 scopus 로고    scopus 로고
    • New antirheumatic drugs: Any real added value? A critical overview of regulatory criteria for their marketing approval
    • Bertele' V, Assisi A, Di Muzio V, Renzo D, Garattini S. New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval. Eur J Clin Pharmacol 2007;63:879-889.
    • (2007) Eur J Clin Pharmacol , vol.63 , pp. 879-889
    • Bertele', V.1    Assisi, A.2    di Muzio, V.3    Renzo, D.4    Garattini, S.5
  • 2
    • 0035342378 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis: New therapeutic approaches with biological agents
    • Afeltra A. Treatment of rheumatoid arthritis: new therapeutic approaches with biological agents. Curr Drug Targets Immune Endocr Metabol Disord 2001;1:45-65.
    • (2001) Curr Drug Targets Immune Endocr Metabol Disord , vol.1 , pp. 45-65
    • Afeltra, A.1
  • 3
    • 78049318396 scopus 로고    scopus 로고
    • Enbrel online, cited on, Nov 20
    • Enbrel [online]. [cited on 2009 Nov 20]; Available from: URL: http://www.enbrel.com/index.jsp
    • (2009)
  • 4
    • 39449135911 scopus 로고    scopus 로고
    • Three signifcant cases of neutropenia with etanercept
    • Wenham C, Gadsby K, Deighton C. Three signifcant cases of neutropenia with etanercept. Rheumatology (Oxford) 2008;47:376-377.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 376-377
    • Wenham, C.1    Gadsby, K.2    Deighton, C.3
  • 6
    • 0043072905 scopus 로고    scopus 로고
    • Acute myelogenous leukaemia following etanercept therapy
    • Bakland G, Nossent H. Acute myelogenous leukaemia following etanercept therapy. Rheumatology (Oxford) 2003;42: 900-901.
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 900-901
    • Bakland, G.1    Nossent, H.2
  • 7
    • 78049299049 scopus 로고    scopus 로고
    • Adverse Efects of Low-Dose Methotrexate in Patients with rheumatoid Arthritis
    • AM Buhroo, AN Baba. Adverse Efects of Low-Dose Methotrexate in Patients with rheumatoid Arthritis IJPMR 2006;17:21-25
    • (2006) IJPMR , vol.17 , pp. 21-25
    • Buhroo, A.M.1    Baba, A.N.2
  • 8
    • 0025891161 scopus 로고
    • Severe pancytopenia in a patient taking low-dose Methotrexate and probenecid
    • Basin KS, escalate A, Beardmore TD. Severe pancytopenia in a patient taking low-dose Methotrexate and probenecid. J Rheumatol 1991;18:609-610.
    • (1991) J Rheumatol , vol.18 , pp. 609-610
    • Basin, K.S.1    Escalate, A.2    Beardmore, T.D.3
  • 9
    • 34547565474 scopus 로고    scopus 로고
    • Antitumor necrosis factor-induced neutropenia: A case report with double positive rechallenges
    • epub 2006 oct 10
    • Montané E, Sallés M, barriocanal A, Riera E, Costa J, tena X. Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges. Clin Rheumatol 2007;26:1527-1529. epub 2006 oct 10.
    • (2007) Clin Rheumatol , vol.26 , pp. 1527-1529
    • Montané, E.1    Sallés, M.2    Barriocanal, A.3    Riera, E.4    Costa, J.5    Tena, X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.